As with all the other companies promising a non-invasive glucose monitor, this technology has little chance for success, except for rabbits.

MBX-2982 could be a potential first-in-class treatment for Type 2 diabetes that may offer improved glucose homeostasis over existing therapies.

The numbers are in and it looks like we have not improved and it will get worse.

Consuming white, oily fish more than once per week may reduce the risk for Type 2 diabetes whereas high consumption of shellfish may increase this risk, according to recent data from the European Prospective Investigation of Cancer-Norfolk cohort study.

Phase III trial results with Boehringer Ingelheim’s DPP-4 inhibitor linagliptin confirm the favourable efficacy and safety profile seen in investigational studies. 

Median A1c was maintained close to 7% for more than 5 years in a cohort of more than 4,000 patients with Type 2 diabetes.

Excessive consumption of confectionery (sweets/chocolates) during childhood can increase the likelihood of adult aggression, according to results from a large cohort study. 

Emergency department physicians rarely adjust antimicrobial medication doses for obese patients, according to new research. 

Gastric electrical stimulation is a reasonable alternative to insulin and oral hypoglycemic agents in obese Type 2 diabetics who are poorly controlled by oral agents and who are not candidates for gastric bypass surgery.

This past weekend I was in California to serve on a panel discussing insulin protocols in both the hospital and long term care settings. There was a lot of great information on what different hospitals did. It was interesting to hear how the choice of pens or vials was made …